buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-Day, Rx Only, 60 count Bottle, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, Manufactured By: Sun Pharmaceutical Ind. Ltd., Halol Baroda Highway, Halol 389 350, Gujarat, India, NDC 47335-738-86
Published August 26, 2015 · Recall initiated: July 17, 2015
Summary
FDA records drug Class III recall D-1345-2015, published August 26, 2015 and initiated July 17, 2015. Recalling firm: Sun Pharma Global Fze; Status: Terminated; Reported quantity: 35,235 bottles; Lot: Lot #s: JKM4152A, JKM4737A, JKM5270A, Exp 08/2015. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email if BUPROPION HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUPROPION HYDROCHLORIDE
- Manufacturer
- Sun Pharma Global Fze
- Distributor
- Nationwide and Puerto Rico
- UPC
- 0347335738865
- Lot
- Lot #s: JKM4152A, JKM4737A, JKM5270A, Exp 08/2015
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United Arab Emirates
Related recalls
- FDABupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: GravitiOctober 29, 2025
- FDAbuPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) perJuly 17, 2024
- FDAbuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for:January 17, 2024
- FDAbuPROPion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, 60 Tablets bottle, Distributed by: SunDecember 13, 2023
- FDA0.9% Sodium Chloride Injection USP, 50 mL Single Dose VIAFLEX Container bags, Rx only, Baxter HealthcareAugust 26, 2015
- FDAunivasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured for UCB, Inc., Smyrna, GA 30080.August 26, 2015
Questions about this recall
Was buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-Day, Rx Only, 60 count Bottle, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, Manufactured By: Sun Pharmaceutical Ind. Ltd., Halol Baroda Highway, Halol 389 350, Gujarat, India, NDC 47335-738-86 recalled?
Yes. FDA published recall D-1345-2015 on August 26, 2015. Reported hazard: Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUPROPION HYDROCHLORIDE. UPC: 0347335738865.